Effect of combining Yoga therapy with Pelvic muscle training to treat inability to hold urine in women on outdoor basis.

Not Applicable

• Conditions: Health Condition 1: N393- Stress incontinence (female) (male)

• Registration Number: CTRI/2024/06/068688
• Lead Sponsor: Mala Bhowmik

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 24 June 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

i.Ambulatory women with the age group between 18 yrs to 60 yrs.

ii.History of involuntary loss of urine for at least 3 months that is a social or hygienic problem.

iii.Documented for minimum 3 episodes of incontinence on a screening 3-day voiding diary.

iv.Participants also agreed to be refrain from other treatment related to incontinence during the trial period.

v.Positive cough stress test.

vi.Women residing within 100 km in radius.

vii.History of stress urinary incontinence according to International Continence Society (ICS).

viii.Urine leakage >4gm measured by pad test with standardized bladder volume.

ix.Willing to give consent for participation in study. They must be motivated to undertake yoga exercises if required.

x.Understands English/Hindi/Bengali.

Exclusion Criteria

The women will be excluded if they,

I.Severe mobility limitation that would prevent from participating in yoga session. Eg. Inability to walk two blocks on level ground or unassisted getting up from supine to standing position within 10 seconds or inability to walk up a single stair.

II.Participants did not use practitioner-supervised pharmacological or clinical treatments for last 3 months.

III.Woman with UI having any of the following symptom’s pain or hematuria (assessed by urine dipstick testing), recurrent infections, interstitial cystitis or chronic pelvic pain, suspected or proven voiding problems, or significant pelvic organ prolapse.

IV.Abnormal bladder function (residual urine >50 ml and maximal uroflow <15ml/s).

V.Women who had delivered a baby in last 6 months.

VI.Women suffering from pelvic malignancy, h/o radical surgery and/or irradiation or anti-incontinent surgery/urethral surgery/or pelvic surgery.

VII.Those taking diuretics and/or excessive caffeine.

VIII.Women with neurological or psychiatric disorders, uncontrolled diabetes mellitus.

Study & Design

• Study Type: Interventional
• Study Design: Not specified